ESSILOR (EPA:EL) ESSILOR - Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2010
Transparency directive : regulatory news
08/02/2010 18:00
Click here to download pdf version
Regulatory Information
Disclosure of Share Capital and Voting Rights
Outstanding as of January 31, 2010
(Pursuant to Article L.233-8 II of the French Commercial Code and articles
221-1 and 223-16 of the General Regulations of the Autorité des Marchés
Financiers)
Charenton-le-Pont, France (February 08, 2010 - 06:00 pm) - As of January 31,
shares and voting rights outstanding of Essilor, the world leader in ophthalmic
optics, broke down as follows:
January 31, 2010
Shares outstanding 215,641,066
Exercisable voting rights 229,441,509
Total potential voting rights, including rights attached
to shares held in treasury and under the liquidity contract. 234,069,912
Essilor International is the world leader in ophthalmic optical products,
offering a wide range of lenses under the flagship Varilux(r), Crizal(r),
Essilor(r) and Definity(r) brands to correct myopia, hyperopia, astigmatism and
presbyopia. Essilor operates worldwide through 15 production sites, 293 lens
finishing laboratories and local distribution networks.
The Essilor share trades on the Euronext Paris market and is included in the
CAC 40 index.
Codes and symbols: ISIN: FR 0000121667; Reuters: ESSI.PA; Bloomberg: EI:FP.
Investor Relations and Financial Communications
www.essilor.com
Phone: +33 (0)1 49 77 42 16